Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,684 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Assessing the risk of breast cancer.
Armstrong K, Eisen A, Weber B. Armstrong K, et al. Among authors: weber b. N Engl J Med. 2000 Feb 24;342(8):564-71. doi: 10.1056/NEJM200002243420807. N Engl J Med. 2000. PMID: 10684916 Review. No abstract available.
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H; Hereditary Breast Cancer Clinical Study Group. Narod SA, et al. Among authors: weber b. Lancet. 2000 Dec 2;356(9245):1876-81. doi: 10.1016/s0140-6736(00)03258-x. Lancet. 2000. PMID: 11130383
SNPs in ultraconserved elements and familial breast cancer risk.
Yang R, Frank B, Hemminki K, Bartram CR, Wappenschmidt B, Sutter C, Kiechle M, Bugert P, Schmutzler RK, Arnold N, Weber BH, Niederacher D, Meindl A, Burwinkel B. Yang R, et al. Among authors: weber bh. Carcinogenesis. 2008 Feb;29(2):351-5. doi: 10.1093/carcin/bgm290. Epub 2008 Jan 3. Carcinogenesis. 2008. PMID: 18174240
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity.
Tchatchou S, Riedel A, Lyer S, Schmutzhard J, Strobel-Freidekind O, Gronert-Sum S, Mietag C, D'Amato M, Schlehe B, Hemminki K, Sutter C, Ditsch N, Blackburn A, Hill LZ, Jerry DJ, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, Wappenschmidt B, Schmutzler RK, Engel C, Meindl A, Bartram CR, Mollenhauer J, Burwinkel B. Tchatchou S, et al. Among authors: weber bh. Hum Mutat. 2010 Jan;31(1):60-6. doi: 10.1002/humu.21134. Hum Mutat. 2010. PMID: 19830809
A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, Wappenschmidt B, Volkmann J, Varon R, Weber BH, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Burwinkel B. Yang R, et al. Among authors: weber bh. Breast Cancer Res Treat. 2010 Jun;121(3):693-702. doi: 10.1007/s10549-009-0633-5. Epub 2009 Nov 18. Breast Cancer Res Treat. 2010. PMID: 19921425
A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
Tchatchou S, Jung A, Hemminki K, Sutter C, Wappenschmidt B, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, Ditsch N, Meindl A, Schmutzler RK, Bartram CR, Burwinkel B. Tchatchou S, et al. Among authors: weber bh. Carcinogenesis. 2009 Jan;30(1):59-64. doi: 10.1093/carcin/bgn253. Epub 2008 Nov 20. Carcinogenesis. 2009. PMID: 19028706
2,684 results